UNITUXIN, created in 2013 (United States), from 16 sister brands and 2214 competing brands. UNITUXIN is owned by United Therapeutics Co., listed on the stock exchange of New York UNITUXIN belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
United Therapeutics Co.
(UNITUXIN)
over 5 years*
USD 554.07